Entries by

Psychedelic Business News Spotlight: April 30, 2021

This week in psychedelic business news: Cybin’s experimental psychedelic takes aim at alcohol use disorder, Numinus seeks volunteers for its natural psilocybin extract, and another psychedelic company trades on Nasdaq.  Toronto-based biotech company Cybin Inc., announced it will focus its proprietary deuterated psychedelic tryptamine CYB003 for the treatment of alcohol use disorder (AUD), a condition that […]